SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

AVARIA, María de los Ángeles et al. Aumento de transaminasas: una manifestación de distrofia muscular de Duchenne. Rev. chil. pediatr. [online]. 2012, vol.83, n.3, pp. 258-261. ISSN 0370-4106.  http://dx.doi.org/10.4067/S0370-41062012000300007.

    1.- Escolar D, Leshner R. Muscular Dystrophies. Pediatric Neurology. Principles and Practice. Swaiman, Ashwal, Ferriero(eds). 4th ed. 2006; 1969-87. [ Links ]

    2.- Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51 (6): 919-28. [ Links ]

    3.- Moxley RT 3rd, Ashwal S, Pandya S, et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice committee of the child Neurology Society. Neurology 2005; 64: 13-20. [ Links ]

    4.- Avaria M, Kleinsteuber K, Herrera L, Carvallo P. Tardanza en el diagnóstico de la distrofia muscular de Duchenne en chile. Rev Med chile 1999; 127: 65-70. [ Links ]

    5.- Ciafaloni E, Fox DJ, Pandya S, et al. Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatrics 2009; 155 (3): 380-85. [ Links ]

    6.- Sibley JA, Lehninger AL. Aldolase in the serum and tissues of tumor-bearing animals. J Natl cancer Inst 1949; 9: 303-9. [ Links ]

    7.- Thomson W, Leyburn P, Walton J. Serum enzyme activity in muscular dystrophy. BMJ 1960; 2: 1276-81. [ Links ]

    8.- Wroblewski F. The clinical significance of transaminase activities of serum. Am J Med 1959; 27: 911-9. [ Links ]

    9.- Pearson CM. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. N Eng J Med 1957; 256: 1069-75. [ Links ]

    10.- Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94: 3010-4. [ Links ]

    11.- Pratt D, Kaplan M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Eng J Med 2000; 342: 1266-71. [ Links ]

    12.- Limdi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgrad Med J 2003; 79: 307-12. [ Links ]

    13.- Henry JB. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia, PA, W. B. Saunders, 1991: 248-84. [ Links ]

    14.- Kohli R, Harris D, Whitington P. Relative Elevations of serum Alanine and Aspartate Aminotransferase in Muscular Dystrophy. J Pediatr Gastroenterol Nutr 2005; 41 (1): 121-4. [ Links ]

    15.- Kasper DL, Fauci AS, Longo DL, Braunwald E. Myo-cardial Infarction. In Harrinson Principles of Internal Medicine. Kasper D, Braunwald E, Fauci AS, Hauser S, Longo DL, Jameson JL.(Eds) 16th ed, Mac Graw Hill, 2005; 1450. [ Links ]

    16.- Rutledge J, Andersen J, Fink CW, Strickland A. Persistent hypertransaminasemia as the presenting finding of childhood muscle disease. Clin Pediatr (Phila) 1985; 24: 500-3. [ Links ]

    17.- Schwarz KB, Burris GC, De Mello DE, et al. Prolonged elevation of transaminase concentration in children with unsuspected myopathy. Am J Dis child 1984; 138: 1121-4. [ Links ]

    18.- Tim RW, Gaskell P, Stajich J. A ''liver test'' is not a liver test. Measuring serum creatine kinase can identify muscular dystrophy and avoid liver biopsy. N C Med J 1998; 59: 238-41. [ Links ]

    19.- Korones DN, Brown MR, Palis J. "Liver function tests'' are not always tests of liver function. Am J Hematol 2001; 66: 46-8. [ Links ]

    20.- Morse RP, Rosman NP. Diagnosis of occult muscular dystrophy: importance of the "chance" finding of elevated serum aminotransferase activities. J Pediatr 1993; 122: 254-6. [ Links ]

    21.- Stein MT, Tipnis NA, Schultz P. Fatigue, decreased interest in play, motor delay, and elevated liver function tests in a 4-year-old boy. J Dev Behav Pediatr 2002; 23: 37-41. [ Links ]

    22.- Zamora S, Adams C, Butzner JD, Machida H, Scott RB. Elevated aminotransferase activity as an indication of muscular dystrophy: case reports and review of the literature. can J Gastroenterol 1996; 10: 389-93. [ Links ]

    23.- Urganci N, Erkan T, Serdaroglu P, Oztelik G, Dogan S, Kayaalp N. A rare cause of high transaminasemia: autosomal muscle dystrophy with gamma sarcoglycan. J Pediatr Gastroenterol Nutr 2001; 32 (3): 327-9. [ Links ]